Trial · NCT07884214
Immunonutrition for Surgical Prehabilitation of Patients With Upper GI Cancer
NCT07884214, Not applicable, Enrolling by invitation, Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Immunonutrition for Surgical Prehabilitation of Patients With Upper GI Cancer. Trials, record NCT07884214. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT07884214
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Immunonutrition for Surgical Prehabilitation of Patients With Upper GI Cancer
- NCT number
- NCT07884214
- Status
- Enrolling by invitation
- Phases
- Not applicable
- Enrollment
- 110 participants, estimated
- Lead sponsor
- Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal
- Conditions
- Upper GI Cancer
- Interventions
- Oral nutritional supplements with immunonutrition (enriched with arginine, nucleotides, vitamin D and omega-3-fatty acid), Standart of care
- First posted
- 2026-10-20
- Last updated
- 2026-10-20
Source ClinicalTrials.gov
Registered outcomes10
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Post-surgical complications | From surgery until 90 days post-hospital discharge | Complications classified as general and post-surgical; severity assessed using the Clavien-Dindo classification and global burden with the ComprehensiveComplication Index (CCI). |
| Secondary | Weight (Kg) | From preoperative evaluation until 90 days after hospital discharge | Weight of the patient at each visit |
| Secondary | Height | From preoperative evaluation until 90 days after hospital discharge | Height of the patient at each visit |
| Secondary | Body mass index (BMI) | From preoperative evaluation until 90 days after hospital discharge | Body mass index of the patients calculated using weight and height |
| Secondary | Weight loss (%) | From preoperative evaluation until 90 days after hospital discharge | Percentage of weight loss from the preoperative baseline weight of the patient |
| Secondary | MUST (malnutrition universal screening tool) score. | From preoperative evaluation until 90 days after hospital discharge | Nutritional assessment by anthropometric methods including weight, weight loss, height, and body mass index, are used to give the MUST (malnutrition universalscreening tool) score. |
| Secondary | Muscle mass - SMMI (cm2/m2) | From preoperative evaluation until 90 days after hospital discharge | Body composition was quantified using preoperative and first postoperative CT scans, analyzing skeletal muscle mass index (SMMI), psoas area, periabdominalmusculature, and fat compartments. |
| Secondary | Psoas muscle index (cm2/m2) | From preoperative evaluation until 90 days after hospital discharge | Body composition was quantified using preoperative and first postoperative CT scans, analyzing skeletal muscle mass index (SMMI), psoas area and index,periabdominal musculature, and fat compartments. |
| Secondary | Subcutaneous fat tissue (cm2) | From preoperative evaluation until 90 days after hospital discharge | Body composition was quantified using preoperative and first postoperative CT scans, analyzing skeletal muscle mass index (SMMI), psoas area, periabdominalmusculature, and fat compartments. |
| Secondary | Visceral fat tissue (cm2) | From preoperative evaluation until 90 days after hospital discharge | Body composition was quantified using preoperative and first postoperative CT scans, analyzing skeletal muscle mass index (SMMI), psoas area, periabdominalmusculature, and fat compartments. |
Source ClinicalTrials.gov
Outcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers0
The papers the trial lists on ClinicalTrials.gov.
None in this release.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT07884214
GET https://conductscience.org/api/trials/v1/NCT07884214/registered